1
|
Sancheznieto F, Sorkness CA, Attia J, Buettner K, Edelman D, Hobbs S, McIntosh S, McManus LM, Sandberg K, Schnaper HW, Scholl L, Umans JG, Weavers K, Windebank A, McCormack WT. Clinical and translational science award T32/TL1 training programs: program goals and mentorship practices. J Clin Transl Sci 2021; 6:e13. [PMID: 35211339 PMCID: PMC8826009 DOI: 10.1017/cts.2021.884] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2021] [Revised: 12/15/2021] [Accepted: 12/16/2021] [Indexed: 01/29/2023] Open
Abstract
INTRODUCTION A national survey characterized training and career development for translational researchers through Clinical and Translational Science Award (CTSA) T32/TL1 programs. This report summarizes program goals, trainee characteristics, and mentorship practices. METHODS A web link to a voluntary survey was emailed to 51 active TL1 program directors and administrators. Descriptive analyses were performed on aggregate data. Qualitative data analysis used open coding of text followed by an axial coding strategy based on the grounded theory approach. RESULTS Fifty out of 51 (98%) invited CTSA hubs responded. Training program goals were aligned with the CTSA mission. The trainee population consisted of predoctoral students (50%), postdoctoral fellows (30%), and health professional students in short-term (11%) or year-out (9%) research training. Forty percent of TL1 programs support both predoctoral and postdoctoral trainees. Trainees are diverse by academic affiliation, mostly from medicine, engineering, public health, non-health sciences, pharmacy, and nursing. Mentor training is offered by most programs, but mandatory at less than one-third of them. Most mentoring teams consist of two or more mentors. CONCLUSIONS CTSA TL1 programs are distinct from other NIH-funded training programs in their focus on clinical and translational research, cross-disciplinary approaches, emphasis on team science, and integration of multiple trainee types. Trainees in nearly all TL1 programs were engaged in all phases of translational research (preclinical, clinical, implementation, public health), suggesting that the CTSA TL1 program is meeting the mandate of NCATS to provide training to develop the clinical and translational research workforce.
Collapse
Affiliation(s)
- Fátima Sancheznieto
- University of Wisconsin Institute for Clinical and Translational Research, Madison, WI, USA
| | - Christine A. Sorkness
- University of Wisconsin Institute for Clinical and Translational Research, Madison, WI, USA
| | - Jacqueline Attia
- Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
| | - Kathryn Buettner
- Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
| | - David Edelman
- Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, USA
| | - Stuart Hobbs
- The Ohio State University, Center for Clinical and Translational Science, Columbus, OH, USA
| | - Scott McIntosh
- Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
| | | | - Kathryn Sandberg
- Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA
| | - H. William Schnaper
- Northwestern University Clinical and Translational Sciences Institute, Northwestern University, Chicago, IL, USA
| | | | - Jason G. Umans
- Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA
| | | | | | - Wayne T. McCormack
- Clinical & Translational Science Institute, Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA
| |
Collapse
|
2
|
Gambichler T, Hamdani N, Budde H, Sieme M, Skrygan M, Scholl L, Dickel H, Behle B, Ganjuur N, Scheel C, Abu Rached N, Ocker L, Stranzenbach R, Doerler M, Pfeiffer L, Becker JC. Bullous pemphigoid after SARS-CoV-2 vaccination: Spike protein-directed immunofluorescence confocal microscopy and T cell receptor studies. Br J Dermatol 2021; 186:728-731. [PMID: 34773638 PMCID: PMC8653321 DOI: 10.1111/bjd.20890] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2021] [Revised: 11/07/2021] [Accepted: 11/08/2021] [Indexed: 11/30/2022]
Affiliation(s)
- T Gambichler
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - N Hamdani
- Institut für Forschung und Lehre (IFL), Department of Molecular and Experimental Cardiology, Ruhr-University Bochum, Bochum, Germany.,Department of Cardiology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.,Institute of Physiology, Ruhr-University, Bochum, Germany
| | - H Budde
- Institut für Forschung und Lehre (IFL), Department of Molecular and Experimental Cardiology, Ruhr-University Bochum, Bochum, Germany.,Department of Cardiology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.,Institute of Physiology, Ruhr-University, Bochum, Germany
| | - M Sieme
- Institut für Forschung und Lehre (IFL), Department of Molecular and Experimental Cardiology, Ruhr-University Bochum, Bochum, Germany.,Department of Cardiology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.,Institute of Physiology, Ruhr-University, Bochum, Germany
| | - M Skrygan
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - L Scholl
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - H Dickel
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - B Behle
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - N Ganjuur
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - C Scheel
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - N Abu Rached
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - L Ocker
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - R Stranzenbach
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - M Doerler
- Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany
| | - L Pfeiffer
- Translational Skin Cancer Research, DKTK Partner Site Essen/Düsseldorf, West German Cancer Center, University Duisburg-Essen, Essen, Germany.,German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - J C Becker
- Translational Skin Cancer Research, DKTK Partner Site Essen/Düsseldorf, West German Cancer Center, University Duisburg-Essen, Essen, Germany.,German Cancer Research Center (DKFZ), Heidelberg, Germany
| |
Collapse
|
3
|
Gambichler T, Scholl L, Dickel H, Ocker L, Stranzenbach R. Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination. J Eur Acad Dermatol Venereol 2021; 35:e415-e416. [PMID: 33725406 PMCID: PMC8251447 DOI: 10.1111/jdv.17225] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2021] [Revised: 02/09/2021] [Accepted: 03/08/2021] [Indexed: 11/30/2022]
Affiliation(s)
- T Gambichler
- Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| | - L Scholl
- Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| | - H Dickel
- Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| | - L Ocker
- Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| | - R Stranzenbach
- Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| |
Collapse
|
4
|
Hessam S, Gambichler T, Skrygan M, Scholl L, Sand M, Meyer T, Stockfleth E, Bechara F. Increased expression profile of NCSTN, Notch and PI3K/AKT3 in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2020; 35:203-210. [DOI: 10.1111/jdv.16962] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2020] [Accepted: 09/14/2020] [Indexed: 12/27/2022]
Affiliation(s)
- S. Hessam
- Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany
- Department of Dermatology and Phlebology Katharinen‐Hospital Unna Unna Germany
| | - T. Gambichler
- Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany
| | - M. Skrygan
- Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany
| | - L. Scholl
- Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany
| | - M. Sand
- Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany
- Department of Plastic and Reconstructive Surgery St. Josef‐Hospital Essen‐Kupferdreh Germany
| | - T. Meyer
- Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany
| | - E. Stockfleth
- Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany
| | - F.G. Bechara
- Department of Dermatology, Venereology and Allergology Ruhr‐University Bochum Bochum Germany
| |
Collapse
|
5
|
Rolland B, Scholl L, Suryanarayanan S, Hatfield P, Judge K, Sorkness C, Burnside E, Brasier AR. Operationalization, implementation, and evaluation of Collaboration Planning: A pilot interventional study of nascent translational teams. J Clin Transl Sci 2020; 5:e23. [PMID: 33948246 PMCID: PMC8057480 DOI: 10.1017/cts.2020.515] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Accepted: 07/15/2020] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND The University of Wisconsin Institute for Clinical and Translational Research hub supports multiple pilot award programs that engage cross-disciplinary Translational Teams. To support those teams, our Team Science group aims to offer a learning experience that is accessible, active, and actionable. We identified Collaboration Planning as a high-impact intervention to stimulate team-building activities that provide Translational Team members with the skills to lead and participate in high-impact teams. METHODS We adapted the published materials on Collaboration Planning to develop a 90-minute facilitated intervention with questions in 10 areas, presuming no previous knowledge of Science of Team Science (SciTS) or team-science best practices. Attendees received a short follow-up survey and submitted a written collaboration plan with their first quarterly progress report. RESULTS Thirty-nine participants from 13 pilot teams from a wide range of disciplines engaged in these sessions. We found that teams struggled to know who to invite, that some of our questions were confusing and too grounded in the language of SciTS, and groups lacked plans for managing their information and communications. We identified several areas for improvement including ensuring that the process is flexible to meet the needs of different teams, continuing to evolve the questions so they resonate with teams, and the need to provide resources for areas where teams needed additional guidance, including information and data management, authorship policies, and conflict management. CONCLUSIONS With further development and testing, Collaboration Planning has the potential to support Translational Teams in developing strong team dynamics and team functioning.
Collapse
Affiliation(s)
- Betsy Rolland
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| | - Linda Scholl
- Mayo Clinic College of Medicine and Science, Rochester, MN, USA
| | - Sainath Suryanarayanan
- Nelson Institute for Environmental Studies, Center for Culture, History and Environment, University of Wisconsin-Madison, Madison, WI, USA
| | - Peggy Hatfield
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| | - Kate Judge
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| | - Christine Sorkness
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| | - Elizabeth Burnside
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| | - Allan R. Brasier
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- Department of Internal Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| |
Collapse
|
6
|
Dodson SE, Kukic I, Scholl L, Pelfrey CM, Trochim WM. A protocol for retrospective translational science case studies of health interventions. J Clin Transl Sci 2020; 5:e22. [PMID: 33948245 PMCID: PMC8057422 DOI: 10.1017/cts.2020.514] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 07/07/2020] [Accepted: 07/13/2020] [Indexed: 11/07/2022] Open
Abstract
The critical processes driving successful research translation remain understudied. We describe a mixed-method case study protocol for analyzing translational research that has led to the successful development and implementation of innovative health interventions. An overarching goal of these case studies is to describe systematically the chain of events between basic, fundamental scientific discoveries and the adoption of evidence-based health applications, including description of varied, long-term impacts. The case study approach isolates many of the key factors that enable the successful translation of research into practice and provides compelling evidence connecting the intervention to measurable changes in health and medical practice, public health outcomes, and other broader societal impacts. The goal of disseminating this protocol is to systematize a rigorous approach, which can enhance reproducibility, promote the development of a large collection of comparable studies, and enable cross-case analyses. This approach, an application of the "science of translational science," will lead to a better understanding of key research process markers, timelines, and potential points of leverage for intervention that may help facilitate decisions, processes, and policies to speed the sustainable translational process. Case studies are effective communication vehicles to demonstrate both accountability and the impacts of the public's investment in research.
Collapse
Affiliation(s)
- Sara E. Dodson
- Office of Science Policy and Planning, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
| | - Ira Kukic
- Office of Evaluation, Performance and Reporting, Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
| | - Linda Scholl
- Office of Applied Scholarship and Education Science, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
| | - Clara M. Pelfrey
- Clinical and Translational Science Collaborative, Case Western Reserve University, Cleveland, OH, USA
| | - William M. Trochim
- Clinical and Translational Science Center, Weill Cornell Medicine, Cornell University, New York, NY, USA
| |
Collapse
|
7
|
Sorkness CA, Scholl L, Fair AM, Umans JG. KL2 mentored career development programs at clinical and translational science award hubs: Practices and outcomes. J Clin Transl Sci 2020; 4:43-52. [PMID: 32257410 PMCID: PMC7103475 DOI: 10.1017/cts.2019.424] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Revised: 08/02/2019] [Accepted: 09/23/2019] [Indexed: 12/16/2022] Open
Abstract
INTRODUCTION NIH Clinical and Translational Science Awards (CTSAs) include KL2 mentored career development awards for faculty commencing clinical and translational research. A survey of KL2 leaders revealed program practices, curricular elements and compelling data about scholar characteristics and outcomes. METHODS We conducted a literature review, framed the survey construct, and obtained input from across the CTSA consortium. A REDCap survey was emailed in fall 2016 to 61 active programs. RESULTS Fifty-five programs (90.2%) responded. Respondents had been funded from 3 to 11 years, including 22 "mature" hubs funded for ≥8 years. Program cohort sizes were 56% "small", 22% "medium", and 22% "large." Hubs offer extensive competency-aligned training opportunities relevant to clinical and translational research, including graduate degrees, mentorship, and grant-writing. Seventy-two percent of hubs report parallel "KL2-equivalent" career development programs. All hubs share their training and facilitate intermingling with other early stage investigators. A total of 1,517 KL2 scholars were funded. KL2 awardees are diverse in their disciplines, research projects, and representation; 54% are female and 12% self-identified as underrepresented in biomedical research. Eighty-seven percent of scholars have 2-3 mentors and are currently supported for 2-3 years. Seventy-eight percent of alumni remain at CTSA institutions in translational science. The most common form of NIH support following scholars' KL2 award is an individual career development award. CONCLUSIONS The KL2 is a unique career development award, shaped by competency-aligned training opportunities and interdisciplinary mentorship that inform translational research pathways. Tracking both traditional and novel outcomes of KL2 scholars is essential to capture their career trajectories and impact on health.
Collapse
Affiliation(s)
- Christine A. Sorkness
- Institute for Clinical and Translational Research, University of Wisconsin-Madison, Madison, WI, USA
| | - Linda Scholl
- Institute for Clinical and Translational Research, University of Wisconsin-Madison, Madison, WI, USA
| | | | - Jason G. Umans
- Georgetown-Howard Universities Center for Clinical Translational Science, Washington, DC, USA
| |
Collapse
|
8
|
Leppin AL, Mahoney JE, Stevens KR, Bartels SJ, Baldwin LM, Dolor RJ, Proctor EK, Scholl L, Moore JB, Baumann AA, Rohweder CL, Luby J, Meissner P. Situating dissemination and implementation sciences within and across the translational research spectrum. J Clin Transl Sci 2019; 4:152-158. [PMID: 32695482 PMCID: PMC7348034 DOI: 10.1017/cts.2019.392] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2019] [Revised: 06/14/2019] [Accepted: 06/17/2019] [Indexed: 12/11/2022] Open
Abstract
The efficient and effective movement of research into practice is acknowledged as crucial to improving population health and assuring return on investment in healthcare research. The National Center for Advancing Translational Science which sponsors Clinical and Translational Science Awards (CTSA) recognizes that dissemination and implementation (D&I) sciences have matured over the last 15 years and are central to its goals to shift academic health institutions to better align with this reality. In 2016, the CTSA Collaboration and Engagement Domain Task Force chartered a D&I Science Workgroup to explore the role of D&I sciences across the translational research spectrum. This special communication discusses the conceptual distinctions and purposes of dissemination, implementation, and translational sciences. We propose an integrated framework and provide real-world examples for articulating the role of D&I sciences within and across all of the translational research spectrum. The framework's major proposition is that it situates D&I sciences as targeted "sub-sciences" of translational science to be used by CTSAs, and others, to identify and investigate coherent strategies for more routinely and proactively accelerating research translation. The framework highlights the importance of D&I thought leaders in extending D&I principles to all research stages.
Collapse
Affiliation(s)
- Aaron L. Leppin
- Department of Health Sciences Research, Mayo Clinic, Mayo Clinic Center for Clinical and Translational Science, Rochester, MN, USA
| | - Jane E. Mahoney
- Division of Geriatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
| | - Kathleen R. Stevens
- Department of Nursing, University of Texas Health Science Center-San Antonio, San Antonio, TX, USA
| | | | - Laura-Mae Baldwin
- Department of Family Medicine, University of Washington, Seattle, WA, USA
| | | | - Enola K. Proctor
- Brown School of Social Work, Washington University in St. Louis, St. Louis, MO, USA
| | - Linda Scholl
- Institute for Clinical and Translational Research, University of Wisconsin-Madison, Madison, WI, USA
| | - Justin B. Moore
- Department of Family and Community Medicine, Wake Forest University, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Ana A. Baumann
- Brown School of Social Work, Washington University in St. Louis, St. Louis, MO, USA
| | - Catherine L. Rohweder
- Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Joan Luby
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
| | - Paul Meissner
- Department of Family and Social Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, USA
| |
Collapse
|
9
|
Patel T, Rainwater J, Trochim WM, Elworth JT, Scholl L, Dave G. Opportunities for strengthening CTSA evaluation. J Clin Transl Sci 2019; 3:59-64. [PMID: 31660229 PMCID: PMC6803463 DOI: 10.1017/cts.2019.387] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2019] [Revised: 05/09/2019] [Accepted: 05/22/2019] [Indexed: 01/14/2023] Open
Abstract
The purpose of the article is to describe the progress of the Clinical and Translational Science Award (CTSA) Program to address the evaluation-related recommendations made by the 2013 Institute of Medicine's review of the CTSA Program and guidelines published in CTS Journal the same year (Trochim et al., Clinical and Translational Science 2013; 6(4): 303-309). We utilize data from a 2018 national survey of evaluators administered to all 64 CTSA hubs and a content analysis of the role of evaluation in the CTSA Program Funding Opportunity Announcements to document progress. We present four new opportunities for further strengthening CTSA evaluation efforts: (1) continue to build the collaborative evaluation infrastructure at local and national levels; (2) make better use of existing data; (3) strengthen and augment the common metrics initiative; and (4) pursue internal and external opportunities to evaluate the CTSA program at the national level. This article will be of significant interest to the funders of the CTSA Program and the multiple stakeholders in the larger consortium and will promote dialog from the broad range of CTSA stakeholders about further strengthening the CTSA Program's evaluation.
Collapse
Affiliation(s)
- Tanha Patel
- Clinical and Translational Science Institute, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Julie Rainwater
- Clinical and Translational Science Center, University of California Davis, Sacramento, CA, USA
| | - William M. Trochim
- Department of Policy Analysis and Management, Cornell University, Ithaca, NY, USA
| | - Julie T. Elworth
- Institute of Translational Health Sciences, University of Washington, Seattle, WA, USA
| | - Linda Scholl
- Institute for Clinical and Translational Research, University of Wisconsin-Madison, Madison, WI, USA
| | - Gaurav Dave
- Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
| |
Collapse
|
10
|
Abstract
Hidradenitis suppurativa/acne inversa (HS/AI) is a chronic inflammatory skin disease. Therapy consists of conservative and surgical treatment options. In Hurley stages II and III, surgical intervention is regarded as the method of choice for areas with irreversible tissue destruction. Resection techniques with different grades of invasiveness are described in the literature. Nevertheless, there is no generally accepted concept regarding resection and reconstruction techniques or specific postoperative care. Due to lack of definitions of recurrence after surgery and poor study quality, recurrence rates are difficult to determine.
Collapse
Affiliation(s)
- L Scholl
- Klinik für Dermatologie, Venerologie und Allergologie, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland
| | - S Hessam
- Klinik für Dermatologie, Venerologie und Allergologie, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland
| | - S Reitenbach
- Klinik für Dermatologie, Venerologie und Allergologie, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland
| | - F G Bechara
- Klinik für Dermatologie, Venerologie und Allergologie, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland.
| |
Collapse
|
11
|
Stefely JA, Theisen E, Hanewall C, Scholl L, Burkard ME, Huttenlocher A, Yu JPJ. A physician-scientist preceptorship in clinical and translational research enhances training and mentorship. BMC Med Educ 2019; 19:89. [PMID: 30917818 PMCID: PMC6438136 DOI: 10.1186/s12909-019-1523-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/03/2019] [Accepted: 03/17/2019] [Indexed: 05/15/2023]
Abstract
BACKGROUND Dual degree program MD/PhD candidates typically train extensively in basic science research and in clinical medicine, but often receive little formal experience or mentorship in clinical and translational research. METHODS To address this educational and curricular gap, the University of Wisconsin Medical Scientist Training Program partnered with the University of Wisconsin Institute for Clinical and Translational Research to create a new physician-scientist preceptorship in clinical and translational research. This six-week apprentice-style learning experience-guided by a physician-scientist faculty mentor-integrates both clinical work and a translational research project, providing early exposure and hands-on experience with clinically oriented research and the integrated career of a physician-scientist. Five years following implementation, we retrospectively surveyed students and faculty members to determine the outcomes of this preceptorship. RESULTS Over five years, 38 students and 36 faculty members participated in the physician-scientist preceptorship. Based on student self-assessments (n = 29, response rate 76%), the course enhanced competency in conducting translational research and understanding regulation of clinical research among other skills. Mentor assessments (n = 17, response rate 47%) supported the value of the preceptorship in these same areas. Based on work during the preceptorship, half of the students produced a peer-reviewed publication or a meeting abstract. At least eleven peer-reviewed manuscripts were generated. The preceptorship also provided a structure for physician-scientist mentorship in the students' clinical specialty of choice. CONCLUSION The physician-scientist preceptorship provides a new curricular model to address the gap of clinical research training and provides for mentorship of physician-scientists during medical school. Future work will assess the long-term impact of this course on physician-scientist career trajectories.
Collapse
Affiliation(s)
- Jonathan A. Stefely
- Medical Scientist Training Program, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
| | - Erin Theisen
- Medical Scientist Training Program, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
| | - Chelsea Hanewall
- Medical Scientist Training Program, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
| | - Linda Scholl
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
| | - Mark E. Burkard
- Medical Scientist Training Program, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
- Department of Medicine, Hematology/Oncology, and the UW Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
| | - Anna Huttenlocher
- Medical Scientist Training Program, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
- Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
| | - John-Paul J. Yu
- Medical Scientist Training Program, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
- Department of Radiology, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI USA
| |
Collapse
|
12
|
Schmitz L, Hessam S, Scholl L, Reitenbach S, Segert MH, Gambichler T, Stockfleth E, Bechara FG. Histological findings after argon plasma coagulation: an ex-vivo study revealing a possible role in superficial ablative treatment of the skin. Arch Dermatol Res 2018; 310:157-163. [PMID: 29350263 DOI: 10.1007/s00403-018-1810-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2017] [Revised: 01/09/2018] [Accepted: 01/12/2018] [Indexed: 10/18/2022]
Abstract
Argon plasma coagulation (APC) is an electrosurgical technique which can be used to ablate skin lesions with limited invasion depth into dermal tissue. Hence, APC might be well suited for the removal of epithelial tumours. However, there are no data on the effects of APC on human skin tissue. Thus, the aim of this study was to determine the extent of epidermal and dermal damage after APC of human skin. We performed APC ex-vivo on 91 freshly resected human skin samples, which were obtained after reconstructive surgical closures in actinically damaged areas. Tissue effects were evaluated histologically and compared across different power settings. Using 15, 30, and 45 W, median (interquartile range; IQR) coagulation depths were 110.0 µm (91.7-130.0), 113.3 µm (85.8-135.0), and 130.0 µm (100.0-153.3.0), respectively. Median (IQR) thickness of necrosis zone was 30.0 µm (23.3-40.0) at 15 W, 26.7 µm (20.0-41.6) at 30 W, and 43.3 µm (30.8-57.5) at 45 W. The Kruskal-Wallis test showed significant differences between 15 and 30 W versus 45 W for coagulation depth (P = 0.0414), necrosis zone (P = 0.0017), and necrosis according to overlaying epidermal thickness (P = 0.0467). In summary, APC is a simple and controllable electrosurgical technique to remove epidermal tissue with limited penetration to the dermis. Thus, APC is particularly suited for the ablation of epithelial skin lesions and, therefore, may serve as possible treatment approach for intraepithelial neoplasms such as actinic keratosis.
Collapse
Affiliation(s)
- L Schmitz
- Department of Dermatology, Venereology and Allergology, Dermatologic Surgery Unit, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
| | - S Hessam
- Department of Dermatology, Venereology and Allergology, Dermatologic Surgery Unit, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
| | - L Scholl
- Department of Dermatology, Venereology and Allergology, Dermatologic Surgery Unit, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
| | - S Reitenbach
- Department of Dermatology, Venereology and Allergology, Dermatologic Surgery Unit, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
| | - M H Segert
- Department of Dermatology, Venereology and Allergology, Dermatologic Surgery Unit, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
| | - T Gambichler
- Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
| | - E Stockfleth
- Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
| | - F G Bechara
- Department of Dermatology, Venereology and Allergology, Dermatologic Surgery Unit, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany.
| |
Collapse
|
13
|
|
14
|
Gambichler T, Rooms I, Scholl L, Stockfleth E, Stücker M, Sand M. BH3-only protein Bim predicts advanced stage of cutaneous melanoma. J Eur Acad Dermatol Venereol 2016; 30:1926-1929. [PMID: 27356803 DOI: 10.1111/jdv.13791] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2016] [Accepted: 05/06/2016] [Indexed: 12/24/2022]
Abstract
BACKGROUND Bim having strong pro-apoptotic effects belongs to the BH3-only proteins of the Bcl-2 protein family and contributes to survival pathways in cancer cells. OBJECTIVES We aimed to investigate Bim protein expression in cutaneous melanoma (CM). METHODS Bim protein expression was assessed by immunohistochemistry in primary and metastatic melanomas and correlated with clinical and histopathological features. RESULTS The Bim immunoreactivity score of the primary melanomas investigated (4.6 ± 1.5) was significantly (P < 0.0001) higher than that observed in metastases (2.8 ± 1.1). Low Bim expression was significantly associated with primary nodular melanoma type (P = 0.005). Moreover, Bim expression was significantly inversely correlated with tumour thickness (r = -0.36; P = 0.0035), advanced stage of disease (stage III and IV; r = -0.60; P < 0.0001), disease relapse (r = -0.18; P = 0.034) and disease-related death (r = -0.19; P = 0.026). Advanced stage of disease was independently predicted by low Bim expression (P = 0.0010, odds ratio: 0.22, 95% CI: 0.10-0.56) on multivariate analysis; however, Bim was not shown to be an independent predictor for disease relapse (P = 0.40) and disease-related death (P = 0.77). CONCLUSIONS Our data demonstrate that Bim protein expression is significantly inversely correlated with melanoma features that are associated with worse prognosis. We have shown that Bim protein expression in CM is an independent predictor for advanced disease confirming that this pro-apoptotic BH3-only protein might be a potent biomarker and promising therapeutic target.
Collapse
Affiliation(s)
- T Gambichler
- Skin Cancer Center of the Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
| | - I Rooms
- Skin Cancer Center of the Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| | - L Scholl
- Skin Cancer Center of the Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| | - E Stockfleth
- Skin Cancer Center of the Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| | - M Stücker
- Skin Cancer Center of the Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| | - M Sand
- Skin Cancer Center of the Department of Dermatology, Ruhr-University Bochum, Bochum, Germany
| |
Collapse
|
15
|
Abstract
This article presents findings from a three-year research study looking at the experiences of students with disabilities who participated in the Wisconsin Youth Apprenticeship program. Specifically, we examined the provision of supports and accommodations. Using in-depth interviews with former program participants and stakeholders and document analysis of participants' school records, the authors discuss type and extent of supports provided to youth apprentices and adequacy of those supports for ensuring students could successfully complete the program. Researchers also examined the perceptions and practices of youth apprenticeship coordinators and instructors concerning accommodation of youth with disabilities in the program. Results suggest a need for stronger and more systematic planning for providing supports and accommodations within youth apprenticeship programs.
Collapse
|
16
|
Gambichler T, Scholl L, Bechara F, Stockfleth E, Stücker M. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients. Eur J Surg Oncol 2016; 42:1420-6. [DOI: 10.1016/j.ejso.2016.03.038] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2016] [Revised: 03/09/2016] [Accepted: 03/31/2016] [Indexed: 11/30/2022] Open
|
17
|
Hessam S, Bruns N, Scholl L, Valavanis K, Bechara F. Der Komet-Lappen zur Rekonstruktion von Exzisionsdefekten im Wangenbereich. Akt Dermatol 2015. [DOI: 10.1055/s-0035-1558610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
18
|
Meier NM, Hessam S, Valavanis K, Scholl L, Bechara F. Operative Therapieoptionen bei Chondrodermatitis nodularis chronica. Akt Dermatol 2015. [DOI: 10.1055/s-0035-1558576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
19
|
Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, Busch M, Maske U, Hapke U, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU. Psychische Störungen in der Allgemeinbevölkerung. Nervenarzt 2014; 85:77-87. [DOI: 10.1007/s00115-013-3961-y] [Citation(s) in RCA: 194] [Impact Index Per Article: 19.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
20
|
Gambichler T, Scholl L. Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma. J Eur Acad Dermatol Venereol 2012; 27:1454-6. [DOI: 10.1111/jdv.12087] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2012] [Accepted: 11/28/2012] [Indexed: 11/30/2022]
Affiliation(s)
- T. Gambichler
- Skin Cancer Center Ruhr-University; Department of Dermatology, Venereology and Allergology; Ruhr-University Bochum; Bochum Germany
| | - L. Scholl
- Skin Cancer Center Ruhr-University; Department of Dermatology, Venereology and Allergology; Ruhr-University Bochum; Bochum Germany
| |
Collapse
|
21
|
Fessel M, Scholl L, Hefti ML. [Isolated hepatomegaly and its sequelae on life expectancy. With a comparative study on excessive alcohol drinking]. Lebensversicher Med 1984; 36:136-9. [PMID: 6148665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|